Melatonin promotes osteoblast differentiation by regulating Osterix protein stability and expression.

Area of Science:

• Biochemistry
• Cell Biology
• Endocrinology

Background:

• Melatonin's role in bone health is suggested but not fully understood.
• The precise molecular mechanisms of melatonin's influence on osteoblast differentiation require elucidation.

Purpose of the Study:

• To investigate the molecular mechanisms of melatonin in osteoblast differentiation.
• To identify the role of osteoblast-specific transcription factors in melatonin's action.

Main Methods:

• Investigated melatonin's effect on BMP-4-induced osteogenic differentiation.
• Analyzed the expression of osteogenic markers, particularly Osterix.
• Examined Osterix degradation pathways and transcriptional activity.
• Utilized protein kinase A (PKA) and protein kinase C (PKC) inhibitors (H89 and Go6976) to probe signaling pathways.

Main Results:

• Melatonin enhanced BMP-4-induced osteogenic differentiation and osteogenic marker expression.
• Melatonin increased Osterix expression by inhibiting its ubiquitin-proteasome-mediated degradation.
• Melatonin up-regulated Osterix transcriptional activity, alkaline phosphatase activity, and bone mineralization.
• PKA and PKC signaling pathways are involved in melatonin's regulation of Osterix phosphorylation and activity.

Conclusions:

• Melatonin directly regulates late-stage osteoblast differentiation by enhancing Osterix expression.
• Melatonin's stabilization of Osterix expression is crucial for promoting osteogenesis.
• These findings support melatonin as a potential therapeutic agent for osteoporosis.